654 related articles for article (PubMed ID: 33721121)
1. An updated review of epidemiology, risk factors, and management of male breast cancer.
Khan NAJ; Tirona M
Med Oncol; 2021 Mar; 38(4):39. PubMed ID: 33721121
[TBL] [Abstract][Full Text] [Related]
2. [Male breast cancer: a review].
Comet B; Cutuli B; Penault-Llorca F; Bonneterre J; Belkacémi Y
Bull Cancer; 2009 Feb; 96(2):181-9. PubMed ID: 19258225
[TBL] [Abstract][Full Text] [Related]
3. Male breast cancer: Outcome with adjuvant treatment.
Yadav BS; Sharma SC; Singh R; Dahiya D; Ghoshal S
J Cancer Res Ther; 2020; 16(6):1287-1293. PubMed ID: 33342786
[TBL] [Abstract][Full Text] [Related]
4. Male breast cancer.
Gómez-Raposo C; Zambrana Tévar F; Sereno Moyano M; López Gómez M; Casado E
Cancer Treat Rev; 2010 Oct; 36(6):451-7. PubMed ID: 20193984
[TBL] [Abstract][Full Text] [Related]
5. Male breast cancer in the United States: Treatment patterns and prognostic factors in the 21st century.
Yadav S; Karam D; Bin Riaz I; Xie H; Durani U; Duma N; Giridhar KV; Hieken TJ; Boughey JC; Mutter RW; Hawse JR; Jimenez RE; Couch FJ; Leon-Ferre RA; Ruddy KJ
Cancer; 2020 Jan; 126(1):26-36. PubMed ID: 31588557
[TBL] [Abstract][Full Text] [Related]
6. New approaches in the management of male breast cancer.
Patten DK; Sharifi LK; Fazel M
Clin Breast Cancer; 2013 Oct; 13(5):309-14. PubMed ID: 23845572
[TBL] [Abstract][Full Text] [Related]
7. Epidemiology and practice patterns for male breast cancer compared with female breast cancer in Japan.
Ishii T; Nakano E; Watanabe T; Higashi T
Cancer Med; 2020 Aug; 9(16):6069-6075. PubMed ID: 32613775
[TBL] [Abstract][Full Text] [Related]
8. Breast cancer in men.
Giordano SH; Buzdar AU; Hortobagyi GN
Ann Intern Med; 2002 Oct; 137(8):678-87. PubMed ID: 12379069
[TBL] [Abstract][Full Text] [Related]
9. Long-term survival and BRCA status in male breast cancer: a retrospective single-center analysis.
Gargiulo P; Pensabene M; Milano M; Arpino G; Giuliano M; Forestieri V; Condello C; Lauria R; De Placido S
BMC Cancer; 2016 Jul; 16():375. PubMed ID: 27377827
[TBL] [Abstract][Full Text] [Related]
10. How to treat male breast cancer.
Czene K; Bergqvist J; Hall P; Bergh J
Breast; 2007 Dec; 16 Suppl 2():S147-54. PubMed ID: 18210656
[TBL] [Abstract][Full Text] [Related]
11. Discordance between oncotype DX recurrence score and RSPC for predicting residual risk of recurrence in ER-positive breast cancer.
Dodson A; Okonji D; Assersohn L; Rigg A; Sheri A; Turner N; Smith I; Parton M; Dowsett M
Breast Cancer Res Treat; 2018 Feb; 168(1):249-258. PubMed ID: 29128896
[TBL] [Abstract][Full Text] [Related]
12. [Clinical research advancement on male breast cancer].
Xue Y; Guo XT; Liu WC
Ai Zheng; 2007 Oct; 26(10):1148-52. PubMed ID: 17927890
[TBL] [Abstract][Full Text] [Related]
13. Management of Male Breast Cancer: ASCO Guideline.
Hassett MJ; Somerfield MR; Baker ER; Cardoso F; Kansal KJ; Kwait DC; Plichta JK; Ricker C; Roshal A; Ruddy KJ; Safer JD; Van Poznak C; Yung RL; Giordano SH
J Clin Oncol; 2020 Jun; 38(16):1849-1863. PubMed ID: 32058842
[TBL] [Abstract][Full Text] [Related]
14. Overview of resistance to systemic therapy in patients with breast cancer.
Gonzalez-Angulo AM; Morales-Vasquez F; Hortobagyi GN
Adv Exp Med Biol; 2007; 608():1-22. PubMed ID: 17993229
[TBL] [Abstract][Full Text] [Related]
15. Gene expression profiling for guiding adjuvant chemotherapy decisions in women with early breast cancer: an evidence-based and economic analysis.
Medical Advisory Secretariat
Ont Health Technol Assess Ser; 2010; 10(23):1-57. PubMed ID: 23074401
[TBL] [Abstract][Full Text] [Related]
16. Male breast cancer: a gender issue.
Nahleh Z; Girnius S
Nat Clin Pract Oncol; 2006 Aug; 3(8):428-37. PubMed ID: 16894388
[TBL] [Abstract][Full Text] [Related]
17. 19. Male breast cancer: aetiology, genetics and clinical management.
Tischkowitz MD; Hodgson SV; Fentiman IS
Int J Clin Pract; 2002 Dec; 56(10):750-4. PubMed ID: 12510948
[TBL] [Abstract][Full Text] [Related]
18. [Clinical and morphological features of breast cancer in men].
Nikolaev KS
Vopr Onkol; 2013; 59(3):358-62. PubMed ID: 23909038
[TBL] [Abstract][Full Text] [Related]
19. Survival benefit of tamoxifen and aromatase inhibitor in male and female breast cancer.
Eggemann H; Altmann U; Costa SD; Ignatov A
J Cancer Res Clin Oncol; 2018 Feb; 144(2):337-341. PubMed ID: 29098396
[TBL] [Abstract][Full Text] [Related]
20. [A case of male breast cancer in which oncotype DX was used to determine the therapeutic strategy].
Yokoyama J; Kobayashi T; Nakamura T; Nakajima Y
Gan To Kagaku Ryoho; 2012 Nov; 39(12):2057-9. PubMed ID: 23267975
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
